Leo Pharma poaches Novo Nordisk VP to lead US division
Leo Pharma has announced that Brian Hilberdink, senior vice president of sales at Novo Nordisk, will become president of Leo Pharma’s US division effective from March 14.
On Thursday, Leo Pharma has announced the appointment of a new EVP and president in the US, Brian Hilberdink, in a company press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Leo Pharma poaches Orphazyme CEO
For subscribers
Leo Pharma's Boston boss exits company
For subscribers
Layoffs and restructuring will prepare Leo Pharma for IPO
For subscribers
